09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
We previously reported on the Bipartisan Budget Act (the “Budget Act”) hardship distribution rule ...
Read More >
INTRODUCTION - Part 1 of this distressed M&A series addressed the unique aspects of acquiring distre...
Read More >
On August 6, 2019, New Jersey amended its Wage and Hour Law and adopted the new Wage Theft Act (WTA)...
Read More >
Recent merger enforcement activities by the Egyptian Competition Authority ("ECA") raise warning sig...
Read More >
On December 31, 2019, the French government issued decree nº 2019-1590 (the 2019 Decree), together w...
Read More >
Continuing a busy summer of changes, on July 29, 2019, Governor Cuomo signed an amendment to New Yor...
Read More >